2008-07-17 23:45:08 -

- BioScrip, Inc. (Nasdaq: BIOS) today announced that it will host a conference call at 10:00 a.m. ET on Thursday, July 31, 2008, to discuss its second quarter operating results for the period ended June 30, 2008. BioScrip will issue a press release announcing the operating results before the market opens on July 31, 2008. Interested parties may participate in

the conference call by dialing 888-214-7562 (US), or 415-537-1802 (international), 5-10 minutes prior to the start of the call. A replay of the conference call will be available from 12:00 p.m. ET on July 31, through 12:00 p.m. ET on August 6, by dialing 800-633-8284 (US), or 402-977-9140 (international) and entering reservation #21389016. An audio webcast and archive of the conference call will also be available under the investor relations section of the BioScrip website, www.bioscrip.com.

About BioScrip, Inc.

BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex healthcare conditions.

BioScrip, Inc.
Craig Allison, 914-460-1636
Director, Corporate Communications
callison@BioScrip.com
or
In-Site Communications
Lisa M. Wilson, 917-543-9932
lwilson@insitecony.com